marginally non-significantp=0.085
At endpoint, subjects in the treatment group were found to have a marginally non-significant higher fasting blood glucose level than subjects taking the placebo (p=0.085).
At endpoint, subjects in the treatment group were found to have a marginally non-significant higher fasting blood glucose level than subjects taking the placebo (p=0.085).